142 related articles for article (PubMed ID: 32527713)
1. In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein.
Kiran G; Karthik L; Shree Devi MS; Sathiyarajeswaran P; Kanakavalli K; Kumar KM; Ramesh Kumar D
J Ayurveda Integr Med; 2022; 13(1):100324. PubMed ID: 32527713
[TBL] [Abstract][Full Text] [Related]
2.
Mandal SK; Rehman MM; Katyal A; Rajvanshi K; Kannan M; Garg M; Murugesan S; Deepa PR
J Tradit Complement Med; 2024 Jan; 14(1):55-69. PubMed ID: 38223813
[TBL] [Abstract][Full Text] [Related]
3. Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach.
Thirumal Kumar D; Shree Devi MS; Udhaya Kumar S; Sherlin A; Mathew A; Lakshmipriya M; Sathiyarajeswaran P; Gnanasambandan R; Siva R; Magesh R; George Priya Doss C
Adv Protein Chem Struct Biol; 2022; 129():275-379. PubMed ID: 35305722
[TBL] [Abstract][Full Text] [Related]
4. Structure-based docking, pharmacokinetic evaluation, and molecular dynamics-guided evaluation of traditional formulation against SARS-CoV-2 spike protein receptor bind domain and ACE2 receptor complex.
Kumar BH; Manandhar S; Mehta CH; Nayak UY; Pai KSR
Chem Zvesti; 2022; 76(2):1063-1083. PubMed ID: 34690412
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the active constituents of Nilavembu Kudineer for viral replication inhibition against SARS-CoV-2: An approach to targeting RNA-dependent RNA polymerase (RdRp).
Kuriakose A; Nair B; Abdelgawad MA; Adewum AT; Soliman MES; Mathew B; Nath LR
J Food Biochem; 2022 Nov; 46(11):e14367. PubMed ID: 35994404
[TBL] [Abstract][Full Text] [Related]
6. Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins.
Jayaraj JM; Jothimani M; Palanisamy CP; Pentikäinen OT; Pannipara M; Al-Sehemi AG; Muthusamy K; Gopinath K
Bioinorg Chem Appl; 2022; 2022():8635054. PubMed ID: 35340421
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial.
Natarajan S; Anbarasi C; Sathiyarajeswaran P; Manickam P; Geetha S; Kathiravan R; Prathiba P; Pitchiahkumar M; Parthiban P; Kanakavalli K; Balaji P
Trials; 2020 Oct; 21(1):892. PubMed ID: 33109252
[TBL] [Abstract][Full Text] [Related]
8. Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized controlled trial, Tamil Nadu, India.
Natarajan S; Anbarasi C; Sathiyarajeswaran P; Manickam P; Geetha S; Kathiravan R; Prathiba P; Pitchiahkumar M; Parthiban P; Kanakavalli K; Balaji P
Trials; 2021 Sep; 22(1):623. PubMed ID: 34526104
[TBL] [Abstract][Full Text] [Related]
9. Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CL
Vincent S; Arokiyaraj S; Saravanan M; Dhanraj M
Front Mol Biosci; 2020; 7():613401. PubMed ID: 33425994
[TBL] [Abstract][Full Text] [Related]
10. The GC-MS Analysis of Kabasura Kudineer: A Vital Siddha Drug in COVID-19 Therapy.
Sudhan A; Prabhu K; Jones S; Balakrishnan D; Muttevi HK; Kalaivannan J
J Pharm Bioallied Sci; 2024 Apr; 16(Suppl 2):S1821-S1823. PubMed ID: 38882785
[TBL] [Abstract][Full Text] [Related]
11. Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening.
Nallusamy S; Mannu J; Ravikumar C; Angamuthu K; Nathan B; Nachimuthu K; Ramasamy G; Muthurajan R; Subbarayalu M; Neelakandan K
Front Pharmacol; 2021; 12():667704. PubMed ID: 34305589
[TBL] [Abstract][Full Text] [Related]
12. An
Sinha SK; Shakya A; Prasad SK; Singh S; Gurav NS; Prasad RS; Gurav SS
J Biomol Struct Dyn; 2021 Jun; 39(9):3244-3255. PubMed ID: 32345124
[TBL] [Abstract][Full Text] [Related]
13. Attitudes, beliefs, and self-use of Kabasura Kudineer among urban and rural population in Tamil Nadu, India: A comparative cross-sectional study.
Bala D
J Family Med Prim Care; 2021 Jan; 10(1):158-166. PubMed ID: 34017720
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic activity of Kabasura Kudineer Chooranam.
Harini P; Veeraraghavan VP; Selvaraj J; Gayathri R; Kavitha S
J Adv Pharm Technol Res; 2022 Dec; 13(Suppl 2):S383-S386. PubMed ID: 36798575
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Kabasura Kudineer tablets in the management of asymptomatic and mild cases of COVID-19: A pilot double-blinded, randomized controlled trial.
Khapre M; Pathania M; Saxena V; Omar BJ; Goyal B; Sinha S; Bahurupi Y; Dhamija P
J Ayurveda Integr Med; 2023; 14(4):100777. PubMed ID: 37536025
[TBL] [Abstract][Full Text] [Related]
16. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking analysis of potential compounds from an Indian medicinal soup "kabasura kudineer" extract with IL-6.
Saleem Basha S; Tripathi D; Koora S; Satyanarayana K; Jayaraman S
Bioinformation; 2020; 17(5):568-572. PubMed ID: 35095231
[TBL] [Abstract][Full Text] [Related]
18. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
[TBL] [Abstract][Full Text] [Related]
19. Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation.
Natesh J; Mondal P; Penta D; Abdul Salam AA; Meeran SM
Comput Biol Med; 2021 Jan; 128():104102. PubMed ID: 33190011
[TBL] [Abstract][Full Text] [Related]
20.
Teli DM; Shah MB; Chhabria MT
Front Mol Biosci; 2020; 7():599079. PubMed ID: 33542917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
